Approval of the merger with Inmagene demonstrates strong shareholder support and confidence in the company's strategic direction. The reverse stock split aims to improve the market perception of the ...
The after-hours surge reflects investor optimism about the strategic merger. The California-based biotech has experienced significant volatility over the past year, trading in a range between $3.03 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback